You are here

Home » Content

Sürekli ayaktan periton diyalizi ve hemodiyaliz hastalarında helicobacter pylori antikor pozitiflik oranı

The prevalence of helicobacter pylori-antibody in hemodialysis and capd patients

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
İn this study, the prevalence of H.pylori-lgG antibody was İnvestigated in 83 hemodialysis (HD) and 30 CAPD patients and compared with those of 45 healthy control group. İn determination of IgG antibody against H.pylori enzyme İmmunoassay ELİSA method was used. Mean ages were 46.2+17.4 and 44.6+15.7 years and dialysis durations were 35.4+ 36.9 months and 20.2+18 months in HD and CAPD patients respectively. Age of control group was 49.4+15.3 (18-80) years. H. Pylori-antibody was positive in 36 HD patients (43.4 %), in 9 CAPD patients (30 %) and in 19 healthy controls (42.2 %). Hp-lgG antibody positivity in HD and CAPD patients was not statisticaliy different from control subjects. İn conclusion, there is no assosiation between Hp-lgG antibody posi¬tivity and age, sex, dyspeptic symptoms two groups. İn this patients Hp IgG positivity should not be evaiuated with-out endoscopic and.histopathoiogic findings.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada hemodiyalize (HD) girmekte olan 83 hasta ile sürekli ayaktan periton diyalizi (SAPD) uygulanan 30 hastada Hp-igG antikor pozitiflik oranı araştırıldı ve 45 sağlıklı kontrol ile karşılaştırıldı. Helicobacter pyloriye (Hp) karşı oluşan IgG antikorlarının tayininde enzim immunoassay ELİSA metodu kullanıldı. HD ve SAPD hastalarının yaş ortalaması sırasıyla, 46.2+17.4 ve 44.6+15.7 yıl ile diyaliz süresi sırasıyla, 35.4+ 36.9 ay ve 20.2+18 ay idi. Kontrol grubunun yaş ortalaması 49.4+15.3 (18-80) yıl idi. HD hastalarının 36'sında (%43.4), SAPD hastalarının 9'unda (%30) ve sağlıklı kontrollerin 19'unda (%42.2) Hp IgG antikoru pozitif idi. Hemodiyaliz ve SAPD hasta¬larında Hp-lgG antikor pozitifliği sağlıklı kontrollerden farklı değildi. Her iki grupta da Hp-igG antikor pozitifliği ile yaş, cinsiyet, diyaliz süresi ve dispeptik yakınmalar arasında ilişki saptanmadı. Sadece Hp antikor pozitifliğine bakarak karar verilmemesi, olguların endoskopik ve histopatolojik olarak da değerlendirilmesi gerektiği sonucuna varıldı.
FULL TEXT (PDF): 
PDF icon arastirmax-surekli-ayaktan-periton-diyalizi-hemodiyaliz-hastalarinda-helicobacter-pylori-antikor-pozitiflik-orani.pdf
  • 4
241-244
  • Turkish

REFERENCES

References: 

1. Hazell SL, Lee A. Camphylobacter pyloridis. urease. hydrogen ion back diffusion. and gastric ulcers. Lancet 1986;2:15-7.
2 Conz P. Ferianİ M. Milan M, Bernardini D, Crepaldi C. La Greca G. Camphylobacter pylori infection in uremic dialysed patients. Nephron 1990;55:442-3.
3. Levi S. VVİnter R. Camphylobacter pylori, duodenal ulcer disease. and gastrin. Br Med J 1989:299:1093-4.
4. Kim H, Park C. Jang Wl. Lee KH, Kwon SO, Robey-Cafferty SS, et al. The gastric juice urea and ammonia levels in patients with Campylobacter pyiori. Am J Clin Pathol 1990;94:187-91.
5. Özden A. Helicobacter pylori'nin yüz yıllık hikayesi. İşte Helicobacter pylori. Türk Gastroenteroloji Derneği 1995:1-3.
6. Marshal! BJ. Helicobacter pylori. The American journal of Gastroenterology 1 994;89:8:116-28.
7. Dooley CP. Background and historical considerations of Helicobacter pyiori. Gastroenterology Clinics of North America 1993;22:1-5.
8. Heatley RV. Helicobacter pylori'nin keşfi. Helicobacter pylori el kitabı 2.baskı p:1-2.
9. Değertekin H. Helicobacter pylori'de tanı yöntemleri. İşte Helicobacter pylori. Türk Gastroenteroloji Derneği 1995; 1-3.
10. Laurence K, Fox JG, Shen Z. Diagnosis of Helicobacter pylori infection in colony of Rhesus Monkeys. Journal of Ciinical Microbiology 1997;35:1:165-8.
11. Karvar S, Karch H, Frosch M, Burghardt W. Gross U. Use of serum-spesific immunoglobulins A and G for detection of Helicobacter pylori infection in patients wfth chronİc gastritis by immunobiot analysis. J Clİn Microbiol 1997:36:3058-61.
12. Yİldiz A. Besisik F, Akkaya V, Sever MS. Bozfakiogiu S. Yilmaz G, Ark E. Helicobacter pylori antibodies in hemodialysis patients and renal transplant recepients. Clin Transplant 1999;13:13-6.
13. Sörberg M. Engstrand L, Ström M, Jönsson KA, Jörbeck H, Granström M. The diagnostic value of enzyme immunoassay and immunobiot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997;29:147-51.
14. Shousha S, Arnout AH, Abbas SH, Parkins RA. Antral Helicobacter pyiori in patients with chronic renal failure. J Ciin Pathol 1990;43:397-9.

15. Davenport A. Shallcross TM. Crabtree JE. Davidson AM. Wiil EJ. Heatley RV, Prevalance of Helicobacter pylori in patients with End-Stage renal failure and renai transplant recepients. Nephron 1991:59:597-601.
16. Derveniotis V. Kolioukas D. Kalekou H. Camphylobacter pylori (Cp) in severely uremic. hemodialysed and successfully transplanted patients. Abstract. XI.th. International Congress of Nephrology. Tokyo. Japan, 1990:138.
17. Mendall MA. Goggin PM. Molineaux N, Levy J. Toosy T. Strachan D. et al. Childhood living conditions and Helicobacter pylori seropositivity İn adult life. Lancet 1992: 339:896-7.
18. Selçuk NY. Onuk MD. Tonbul Z. Akçay F. Nasuhbeyoğlu N. Kronik böbrek yetmezliği ve dispepsili olan hastalarda kültür ve antikorla helicobacter pylori sıklığı. T Klin Gastroenterohepatol 1996:7:145-8.
19. Hruby Z. Myszka-Bijak K, Gosciniak G. Blaszczuk J, Czyz W. Kowalski P, et al. Helicobacter pylori in kidney allograft recipients: high prevalence of colonization and low incidence of active inflamatory lesions. Nephron 1997;75:1:25-9.
20. Luzza F. Imeneo M, Maletta M. Mantelli I, Tancre D, Merando G. et al. Helicobacter pylori-spesific IgG in chronic haemodialysis patients: relationship of hyper-gastrinaemia to posîtîve serology. Nephrol Dial Transplant 1996;11:1:120-4.
21. Giachino G, Sallio Bruno F, Chiappero F. Saltarelli M. Rosati C. Mazzucco D. Helicobacter pylori in patients undergoing periodic hemodialysis. Minerva Urol Nefrol 1994:46:4.213-5.
22. Moustafa FE, Khalil A. Abdel VVahap M, Sobh MA. He'':obacter pylori and uremic gastritis; a histopatho-log'. study and a correiation with endoscopic and bac-teriuiogic findings. Am J Nephrol 1997:17:165-71.
23. Süleymanlar I, Tuncer M. Tuğrul Sezer M. Ertugrul C. Sarİkaya M. Fevzi Ersoy F. Response to triple treat-ment with omeprazoie, amoxicilin, and clarithromycin for helicobacter pylori infections in continuous ambula-tory peritoneal dialysis patients, Adv Perit Dial 1999:15:79-81.
24. Gladziwa U, Haase G. Handt S, Rİehl J, Wietholtz H. Dakshinamurty KV, et al. Prevalance of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transplant 1993;8:301-6.

Thank you for copying data from http://www.arastirmax.com